U.S. markets open in 5 hours 29 minutes

Nymox Pharmaceutical Corporation (NYMX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.7600-0.0300 (-1.68%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 5/6/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) 1.47
52-Week Change 3-44.92%
S&P500 52-Week Change 347.47%
52 Week High 34.7900
52 Week Low 31.6800
50-Day Moving Average 32.1888
200-Day Moving Average 32.3725

Share Statistics

Avg Vol (3 month) 3266.54k
Avg Vol (10 day) 3347.76k
Shares Outstanding 578.71M
Implied Shares Outstanding 6N/A
Float 44.89M
% Held by Insiders 144.97%
% Held by Institutions 16.59%
Shares Short (Apr 14, 2021) 43.96M
Short Ratio (Apr 14, 2021) 419.07
Short % of Float (Apr 14, 2021) 49.13%
Short % of Shares Outstanding (Apr 14, 2021) 45.03%
Shares Short (prior month Mar 14, 2021) 43.77M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020


Profit Margin 0.00%
Operating Margin (ttm)-234,400.00%

Management Effectiveness

Return on Assets (ttm)-149.00%
Return on Equity (ttm)-419.74%

Income Statement

Revenue (ttm)5k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)-100.00%
Gross Profit (ttm)1k
EBITDA -11.71M
Net Income Avi to Common (ttm)-11.74M
Diluted EPS (ttm)-0.1590
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.61M
Total Cash Per Share (mrq)0.05
Total Debt (mrq)426k
Total Debt/Equity (mrq)19.86
Current Ratio (mrq)2.13
Book Value Per Share (mrq)0.03

Cash Flow Statement

Operating Cash Flow (ttm)-10.04M
Levered Free Cash Flow (ttm)-5.68M